文献速递泌尿生殖腹部MR

基于定量多参数MR成像表征Gleason评分至少7分的前列腺癌:在接受前列腺活检患者中对计算机辅助诊断系统的验证

Characterization of Prostate Cancer with Gleason Score of at Least 7 by Using Quantitative Multiparametric MR Imaging: Validation of a Computer-aided Diagnosis System in Patients Referred for Prostate Biopsy.
PubMed 文献 · Radiology · 2018-01-22

本研究回顾性使用两个前瞻性数据库,训练计算机辅助诊断(CAD)系统以表征外周带Gleason评分至少7分的前列腺癌,并在独立活检患者中验证。CAD在总体人群及多数亚组中优于活检时前瞻性评分的五级Likert评分,尤其对经验不足1年的放射科医师。

要点

  • CAD在外周带Gleason评分至少7分前列腺癌的逐患者分析中AUC为0.95,优于Likert评分的0.88(P=0.02)。
  • 对经验不足1年放射科医师,CAD逐病灶AUC为0.90 vs Likert 0.83(P=0.04)。
  • CAD在移行区未显示优于Likert评分。

核心结论

  • CAD在表征Gleason评分至少7分前列腺癌方面优于活检时前瞻性评分的Likert评分。

研究设计与样本

  • 回顾性使用两个经机构审查委员会批准的前瞻性数据库:数据库1为前列腺切除术前接受多参数MR成像的患者,数据库2为接受系统与靶向活检的患者。
  • CAD在数据库1的106例患者中训练,结合表观扩散系数的第10百分位数与强化达峰时间,检测外周带Gleason评分至少7分的癌症。
  • CAD在数据库2的129例不同患者中测试,以活检结果为参考标准。

诊断标准与关键数值

  • 逐患者分析:CAD的AUC为0.95(95%CI:0.90,0.98),Likert评分为0.88(95%CI:0.68,0.96),P=0.02。
  • 经验不足1年放射科医师逐病灶分析:CAD的AUC为0.90(95%CI:0.81,0.95),Likert评分为0.83(95%CI:0.73,0.90),P=0.04。
  • 经验不足1年放射科医师逐肺叶分析:CAD的AUC为0.92(95%CI:0.80,0.96),Likert评分为0.84(95%CI:0.72,0.91),P=0.04。

临床应用与阅片要点

  • 靶向病灶在活检时前瞻性采用五级Likert评分,CAD评分回顾性计算。
  • CAD在总体人群及除移行区外的所有亚组中均优于Likert评分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To determine the performance of a computer-aided diagnosis (CAD) system trained at characterizing cancers in the peripheral zone (PZ) with a Gleason score of at least 7 in patients referred for multiparametric magnetic resonance (MR) imaging before prostate biopsy. Materials and Methods Two institutional review board-approved prospective databases of patients who underwent multiparametric MR imaging before prostatectomy (database 1) or systematic and targeted biopsy (database 2) were retrospectively used. All patients gave informed consent for inclusion in the databases. A CAD combining the 10th percentile of the apparent diffusion coefficient and the time to peak of enhancement was trained to detect cancers in the PZ with a Gleason score of at least 7 in 106 patients from database 1. The CAD was tested in 129 different patients from database 2. All targeted lesions were prospectively scored at biopsy by using a five-level Likert score. The CAD scores were retrospectively calculated. Biopsy results were used as the reference standard. Areas under the receiver operating characteristic curves (AUCs) were computed for CAD and Likert scores by using binormal smoothing for per-lesion and per-lobe analyses, and a density function for per-patient analysis. Results The CAD outperformed the Likert score in the overall population and all subgroups, except in the transition zone. The difference was statistically significant for the overall population (AUC, 0.95 [95% confidence interval {CI}: 0.90, 0.98] vs 0.88 [95% CI: 0.68, 0.96]; P = .02) at per-patient analysis, and for less-experienced radiologists (<1 year) at per-lesion (AUC, 0.90 [95% CI: 0.81, 0.95] vs 0.83 [95% CI: 0.73, 0.90]; P = .04) and per-lobe (AUC, 0.92 [95% CI: 0.80, 0.96] vs 0.84 [95% CI: 0.72, 0.91]; P = .04) analysis. Conclusion The CAD outperformed the Likert score prospectively assigned at biopsy in characterizing cancers with a Gleason score of at least 7. © RSNA, 2018 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Dinh AH, Melodelima C, Souchon R, et al. Characterization of Prostate Cancer with Gleason Score of at Least 7 by Using Quantitative Multiparametric MR Imaging: Validation of a Computer-aided Diagnosis System in Patients Referred for Prostate Biopsy. Radiology. 2018. PMID: 29361244. doi:10.1148/radiol.2017171265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。